111 related articles for article (PubMed ID: 31335171)
1. Demystifying the Pizza Bolus: The Effect of Dough Fermentation on Glycemic Response-A Sensor-Augmented Pump Intervention Trial in Children with Type 1 Diabetes Mellitus.
Zanfardino A; Confetto S; Curto S; Cocca A; Rollato AS; Zanfardino F; Troise AD; Testa V; Bologna O; Stanco M; Piscopo A; Cohen O; Miraglia Del Giudice E; Vitaglione P; Iafusco D
Diabetes Technol Ther; 2019 Dec; 21(12):721-726. PubMed ID: 31335171
[No Abstract] [Full Text] [Related]
2. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
[TBL] [Abstract][Full Text] [Related]
3. Lowering postprandial glycemia in children with type 1 diabetes after Italian pizza "margherita" (TyBoDi2 Study).
De Palma A; Giani E; Iafusco D; Bosetti A; Macedoni M; Gazzarri A; Spiri D; Scaramuzza AE; Zuccotti GV
Diabetes Technol Ther; 2011 Apr; 13(4):483-7. PubMed ID: 21355715
[TBL] [Abstract][Full Text] [Related]
4. The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.
Piechowiak K; Dżygało K; Szypowska A
Pediatr Diabetes; 2017 Dec; 18(8):861-868. PubMed ID: 28117542
[TBL] [Abstract][Full Text] [Related]
5. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
[TBL] [Abstract][Full Text] [Related]
6. Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.
O'Connell MA; Gilbertson HR; Donath SM; Cameron FJ
Diabetes Care; 2008 Aug; 31(8):1491-5. PubMed ID: 18509207
[TBL] [Abstract][Full Text] [Related]
7. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
8. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
Kordonouri O; Hartmann R; Remus K; Bläsig S; Sadeghian E; Danne T
Pediatr Diabetes; 2012 Nov; 13(7):540-4. PubMed ID: 22765260
[TBL] [Abstract][Full Text] [Related]
9. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
10. Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study.
Pańkowska E; Błazik M; Groele L
Diabetes Technol Ther; 2012 Jan; 14(1):16-22. PubMed ID: 22013887
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
12. Insulin delivery patterns required to maintain postprandial euglycemia in type 1 diabetes following consumption of traditional Egyptian Ramadan Iftar meal using insulin pump therapy: A randomized crossover trial.
Elbarbary NS; Elhenawy YI; Ali ARR; Smart CE
Pediatr Diabetes; 2022 Dec; 23(8):1628-1634. PubMed ID: 36285573
[TBL] [Abstract][Full Text] [Related]
13. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
14. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
15. Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia.
Heptulla RA; Rodriguez LM; Mason KJ; Haymond MW
J Clin Endocrinol Metab; 2009 May; 94(5):1608-11. PubMed ID: 19190104
[TBL] [Abstract][Full Text] [Related]
16. Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.
Thuillier P; Sonnet E; Alavi Z; Roudaut N; Nowak E; Dion A; Kerlan V
Diabetes Metab Res Rev; 2018 Sep; 34(6):e3019. PubMed ID: 29749032
[TBL] [Abstract][Full Text] [Related]
17. Effects of multiple daily injection therapy with Humalog mixtures versus separately injected insulin lispro and NPH insulin in adults with type I diabetes mellitus.
Roach P; Bai S; Charbonnel B; Consoli A; Taboga C; Tiengo A; Bolli G;
Clin Ther; 2004 Apr; 26(4):502-10. PubMed ID: 15189747
[TBL] [Abstract][Full Text] [Related]
18. Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
Rabasa-Lhoret R; Garon J; Langelier H; Poisson D; Chiasson JL
Diabetes Care; 1999 May; 22(5):667-73. PubMed ID: 10332663
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of additional bolus insulin using an insulin-to-protein ratio compared with insulin-to-carbohdrate ratio alone in people with type 1 diabetes following a carbohydrate-restricted diet.
Hall RM; Marshall HJ; Parry-Strong A; Corley B; Krebs JD
J Diabetes Complications; 2024 Jul; 38(7):108778. PubMed ID: 38820834
[TBL] [Abstract][Full Text] [Related]
20. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
